Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., develops and distributes spinal implant products in Canada.
Adequate balance sheet with weak fundamentals.
Share Price & News
How has Aurora Spine's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ASG's share price has been volatile over the past 3 months.
7 Day Return
CA Medical Equipment
1 Year Return
CA Medical Equipment
Return vs Industry: ASG underperformed the Canadian Medical Equipment industry which returned 1.3% over the past year.
Return vs Market: ASG underperformed the Canadian Market which returned -12.5% over the past year.
Price Volatility Vs. Market
How volatile is Aurora Spine's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StShould You Take Comfort From Insider Transactions At Aurora Spine Corporation (CVE:ASG)?
1 month ago | Simply Wall StThose Who Purchased Aurora Spine (CVE:ASG) Shares Five Years Ago Have A 79% Loss To Show For It
2 months ago | Simply Wall StHow Does Aurora Spine Corporation (CVE:ASG) Affect Your Portfolio Volatility?
Is Aurora Spine undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate ASG's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate ASG's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: ASG is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.
PE vs Market: ASG is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ASG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ASG is overvalued based on its PB Ratio (5.2x) compared to the CA Medical Equipment industry average (4.1x).
How is Aurora Spine forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aurora Spine has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Aurora Spine's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Aurora Spine competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Aurora Spine performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ASG is currently unprofitable.
Growing Profit Margin: ASG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ASG is unprofitable, but has reduced losses over the past 5 years at a rate of 48.7% per year.
Accelerating Growth: Unable to compare ASG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ASG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.4%).
Return on Equity
High ROE: ASG has a negative Return on Equity (-70.94%), as it is currently unprofitable.
How is Aurora Spine's financial position?
Financial Position Analysis
Short Term Liabilities: ASG's short term assets ($4.7M) exceed its short term liabilities ($2.5M).
Long Term Liabilities: ASG's short term assets ($4.7M) exceed its long term liabilities ($2.4M).
Debt to Equity History and Analysis
Debt Level: ASG's debt to equity ratio (120.5%) is considered high.
Reducing Debt: ASG's debt to equity ratio has increased from 0.02% to 120.5% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ASG has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ASG is forecast to have sufficient cash runway for 9 months based on free cash flow estimates, but has since raised additional capital.
What is Aurora Spine current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ASG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ASG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ASG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ASG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ASG's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Trent Northcutt (53yo)
Mr. Trent J. Northcutt is the Chief Executive Officer and President at Aurora Spine Corporation since February 2012. Mr. Northcutt served as Vice President at Spineart Inc. Prior to working for Spineart In ...
CEO Compensation Analysis
Compensation vs Market: Trent's total compensation ($USD0.00) is below average for companies of similar size in the Canadian market ($USD173.09K).
Compensation vs Earnings: Trent's compensation has increased whilst the company is unprofitable.
|Independent Chairman||4.75yrs||US$20.28k||15.95% $2.4m|
|Independent Director||7yrs||US$2.02k||0.13% $18.9k|
|Independent Director||7yrs||US$1.98k||0.71% $106.1k|
|Independent Director||7yrs||US$2.50k||1.98% $295.8k|
|Independent Director||7yrs||US$1.73k||0.18% $26.2k|
Experienced Board: ASG's board of directors are considered experienced (7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.3%.
Aurora Spine Corporation's company bio, employee growth, exchange listings and data sources
- Name: Aurora Spine Corporation
- Ticker: ASG
- Exchange: TSXV
- Founded: 2013
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: CA$14.961m
- Shares outstanding: 55.41m
- Website: https://www.aurora-spine.com
- Aurora Spine Corporation
- 20 Holly Street
- Suite 300
- M4S 3B1
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ASG||TSXV (TSX Venture Exchange)||Yes||Common Shares||CA||CAD||Sep 2013|
|AROS.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Sep 2013|
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., develops and distributes spinal implant products in Canada. The company offers interspinous process lumbar fusion devices for patients suffering from degenerative disc diseases; Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae and bone grows to complete the fusion process; sterile-packed titanium plasma spray coated spinal infusion implants for bone growth; and 3D Printed Stand Alone ALIF Cage, an integrated plate and spacer system that helps to preserve the natural anatomic profile, and provides spinal column support and stability. The company was incorporated in 2013 and is headquartered in Toronto, Canada.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/07/09 00:06|
|End of Day Share Price||2020/07/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.